Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
about
Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.Perspectives of HER2-targeting in gastric and esophageal cancer.Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.HER2 and β-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations.Suppression of Kpnβ1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2.MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers.Development of a Nanostructured Platform for Identifying HER2-Heterogeneity of Breast Cancer Cells by Surface-Enhanced Raman Scattering
P2860
Q36629433-0C8FF0EC-B50E-4F7A-8C78-BFEB15A7C09CQ37668848-D382D0A0-566C-4ABD-AD72-132A8FA8B161Q38848389-0BBF810E-5CD0-41C8-8B41-9C9A3FC26014Q38849205-2ADFF1D2-4014-4CB8-8C06-C8B2452F47F9Q38914809-C409DB94-ED49-4095-BB59-6D1D97467CD7Q47282308-1CDB91D3-3BF9-41D9-80A2-B88FB0999FDAQ50417171-A6339A16-F71C-4437-9F7D-246C75A93245Q51646294-BAD5D763-3086-4097-B62D-1BB5877468BEQ57139047-F7159C60-8EFE-4A5E-81DE-1E314D408314
P2860
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Targeting ErbB-2 nuclear local ...... rcomes trastuzumab resistance.
@en
Targeting ErbB-2 nuclear local ...... rcomes trastuzumab resistance.
@nl
type
label
Targeting ErbB-2 nuclear local ...... rcomes trastuzumab resistance.
@en
Targeting ErbB-2 nuclear local ...... rcomes trastuzumab resistance.
@nl
prefLabel
Targeting ErbB-2 nuclear local ...... rcomes trastuzumab resistance.
@en
Targeting ErbB-2 nuclear local ...... rcomes trastuzumab resistance.
@nl
P2093
P2860
P50
P356
P1433
P1476
Targeting ErbB-2 nuclear local ...... ercomes trastuzumab resistance
@en
P2093
C J Proietti
E H Charreau
L Venturutti
M C Díaz Flaqué
N A O'Brien
N Galigniana
W Béguelin
P2860
P2888
P304
P356
10.1038/ONC.2014.272
P407
P577
2014-09-01T00:00:00Z
P6179
1050309476